Partial Stereotactic Ablative Radiotherapy Boost before Conventional Radiotherapy (P-SABR) for Large (> 5 cm) Unresectable Soft Tissue Sarcoma

被引：0
|
作者：
Bai, Y. [1 ]
Gao, X. [1 ]
Qin, S. [1 ]
Li, S. [1 ]
Ma, M. [1 ]
Liu, S. [1 ]
Gao, Y. [1 ]
机构：
[1] Peking Univ First Hosp, Dept Radiat Oncol, Beijing, Peoples R China
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2024年 / 120卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2951
引用
收藏
页码：E428 / E428
页数：1
相关论文
共 13 条
  • [1] Partial Stereotactic Ablative Radiotherapy Boost Before Conventional Radiotherapy (P-SABR) for Large (> 5 cm) Unresectable Stage III Nonsmall Cell Lung Cancer
    Bai, Yun
    Gao, Xianshu
    Qin, Shangbin
    Li, Shanshi
    Ma, Mingwei
    Cao, Xi
    Lyu, Feng
    Chen, Jiayan
    Qi, Xin
    Liu, Siwei
    Gao, Yan
    Li, Hongzhen
    Li, Xiaomei
    Li, Xiaoying
    Ren, Xueying
    Huang, Lei
    THORACIC CANCER, 2025, 16 (02)
  • [2] Preliminary Study on Immunological Mechanism of Partial Stereotactic Ablative Boost Radiotherapy (P-SABR)
    Li, S.
    Bai, Y.
    Gao, X.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E380 - E380
  • [3] Neoadjuvant stereotactic ablative radiotherapy (SABR) for soft tissue sarcomas of the extremities
    Leite, Elton Trigo Teixeira
    Munhoz, Rodrigo Ramella
    de Camargo, Veridiana Pires
    de Lima, Luiz Guilherme Cernaglia Aureliano
    Rebolledo, Daniel Cesar Seguel
    Maistro, Carlos Eduardo Bravin
    Busnardo, Fabio de Freitas
    Ferreira, Fabio de Oliveira
    Salvajoli, Joao Victor
    Carvalho, Heloisa de Andrade
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : 222 - 229
  • [4] Stereotactic Ablative Radiotherapy for oligometastatic soft tissue sarcoma patients
    Greto, D.
    Loi, M.
    Pezzulla, D.
    Lo Russo, M.
    Teriaca, M. A.
    Maragna, V.
    Lucidi, S.
    Campanacci, D. A.
    Beltrami, G.
    Scoccianti, G.
    Livi, L.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S866 - S866
  • [5] Treatment-related neuroendocrine prostate cancer managed with partial stereotactic ablative radiotherapy (P-SABR) for long-term survival: a case series
    Qi, Xin
    Zhang, Zhuo-Fei
    Gao, Xian-Shu
    Qin, Shang-Bin
    Bai, Yun
    Yu, Wei
    He, Qun
    Fan, Yu
    Zhang, Jian-Hua
    Jiang, Yuan
    He, Zhi-Song
    Li, Hong -Zhen
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2023, 12 (01) : 128 - +
  • [6] Proton Partial Stereotactic Ablative Boost Radiotherapy Delivered Higher BED in Large NSCLC
    Bai, Y.
    Gao, X.
    Ma, M.
    Ren, X. Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E698 - E699
  • [7] Use of Stereotactic Ablative Radiotherapy (SABR) in Non-Small Cell Lung Cancer Measuring More Than 5 cm
    Tekatli, Hilal
    van't Hof, Saar
    Nossent, Esther J.
    Dahele, Max
    Verbakel, Wilko F. A. R.
    Slotman, Ben J.
    Senan, Suresh
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (06) : 974 - 982
  • [8] Preoperative stereotactic ablative body radiotherapy with postoperative conventional irradiation of soft tissue sarcomas: Protocol overview with a preliminary safety report
    Novikov, S. N.
    Gafton, G. I.
    Ebert, M. A.
    Fedosova, E. A.
    Melnik, J. S.
    Zinovev, G. V.
    Gafton, I. G.
    Sinyachkin, M. S.
    Kanaev, S. V.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : 126 - 131
  • [9] Preoperative stereotactic ablative body radiotherapy with postoperative conventional irradiation of soft tissue sarcomas: Protocol overview with a preliminary safety report.
    Ebert, Mariia
    Novikov, Sergey
    Zinovev, Grigory
    Gafton, Georgy
    Protsenko, Svetlana
    Gafton, Ivan
    Sinyachkin, Mikhail
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [10] Microwave Ablation, Radiofrequency Ablation, Irreversible Electroporation, and Stereotactic Ablative Body Radiotherapy for Intermediate Size (3–5 cm) Unresectable Colorectal Liver Metastases: a Systematic Review and Meta-analysis
    Sanne Nieuwenhuizen
    Madelon Dijkstra
    Robbert S. Puijk
    Bart Geboers
    Alette H. Ruarus
    Evelien A. Schouten
    Karin Nielsen
    Jan J. J. de Vries
    Anna M. E. Bruynzeel
    Hester J. Scheffer
    M. Petrousjka van den Tol
    Cornelis J. A. Haasbeek
    Martijn R. Meijerink
    Current Oncology Reports, 2022, 24 : 793 - 808
12